1. References:
1. McGraw SL, Ferrante JM. Update on the prevention and screening of cervical cancer. World journal of clinical oncology. 2014;5(4):744.
2. Bueno CT, Silva CMDd, Barcellos RB, Silva Jd, Santos CRd, Menezes JES, et al. Association between cervical lesion grade and micronucleus frequency in the Papanicolaou test. Genetics and molecular biology. 2014;37(3):496-9.
3. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Annals of oncology. 2011;22(12):2675-86.
4. Barut MU, Kale A, Kuyumcuoğlu U, Bozkurt M, Ağaçayak E, Özekinci S, et al. Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in the diagnosis of premalignant and malignant cervical lesions. Medical science monitor: international medical journal of experimental and clinical research. 2015;21:3860.
5. Koh W-J, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. Cervical cancer, version 2.2015. Journal of the National Comprehensive Cancer Network. 2015;13(4):395-404.
6. Pandey K, Bhagoliwal A, Jain S. Optical imaging: a future tool in the detection of pre-cancerous and cancerous lesions of the cervix and its comparison to colposcopy. The Journal of Obstetrics and Gynecology of India. 2015;65(3):176-80.
7. Giannella L. The clinical problem of colposcopy is represented by false-negatives. Archives of gynaecology and obstetrics. 2015;291(4):711-2.
8. Sakano C, Ribalta J, Zucchi P. Tracking of cervical cancer in 7,519 patients: a study of the prevalence of altered cytologies. European journal of gynaecological oncology. 2015;36(4):437-41.
9. Mayeaux Jr EJ, Harper MB, Abreo F, Pope JB, Phillips GS. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology. Journal of Family Practice. 1995;40(1):57-63.
10. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecologic oncology. 2001;82(3):516-22.
11. Karimi-Zarchi M, Peighmbari F, Karimi N, Rohi M, Chiti Z. A comparison of 3 ways of conventional pap smear, liquid-based cytology and colposcopy vs cervical biopsy for early diagnosis of premalignant lesions or cervical cancer in women with an abnormal conventional pap test. International journal of biomedical science: IJBS. 2013;9(4):205.
12. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New England journal of medicine. 1992;327(18):1272-8.
13. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health centre. Archives of Family Medicine. 1999;8(2):129.
14. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. American journal of obstetrics and gynaecology. 1999;181(3):560-6.
15. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International journal of cancer. 2006;119(5):1095-101.
16. Farzaneh F, Tamimi M, Amiri Z, Alizadeh K. The value of Pap smear in detecting cervical neoplasia compared with histopathologic findings in patients referred to Taleghani Hospital, Tehran 2007-2009. 2011.
17. Moy LM, Zhao FH, Li LY, Ma JF, Zhang QM, Chen F, et al. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral. International journal of cancer. 2010;127(3):646-56.
18. Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecologic oncology. 1998;68(3):233-9.
19. McAdam M, Sakita J, Tarivonda L, Pang J, Frazer IH. Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting. PloS one. 2010;5(10):e13266.
20. Sayyah-Melli M, Rahmani V, Ouladsahebmadarek E, Jafari-Shobeiri M, Gharabaghi PM, Vahidi MN. Diagnostic Value of Pap Smear and Colposcopy in Non-benign Cervical Lesions. morbidity and mortality. 2017;2:4.
21. Zarchi MK, Binesh F, Kazemi Z, Teimoori S, Soltani HR. Value of Colposcopy in the Early Diagnosis of Cervical Cancer in Abnormal Pap Smears in Patients Referred to the Gynecology-Oncology Clinic at Shahid Sadoughi Hospital, Yazd. Asian Pacific Journal of Cancer Prevention. 2011;12:3439-41.
22. Ghaem Maghami F, Ensani F, Behtash N, Hosseini Nejad S. Histologic findings of the uterine cervix among women with a cytologic diagnosis of ASCUS (atypical squamous cells of undetermined significance). Tehran University Medical Journal TUMS Publications. 2004;62(4):326-31.
23. Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M. Early cervical neoplasia confirmed by conization. Acta Cytol. 1996;40:241-6.
2. Update on prevention and screening of cervical cancer
3. Association between cervical lesion grade and micronucleus frequency in the Papanicolaou test
4. Worldwide burden of cervical cancer in 2008
5. Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions